BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10747825)

  • 1. Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa.
    Smith RP; Baltch AL; Franke MA; Michelsen PB; Bopp LH
    J Antimicrob Chemother; 2000 Apr; 45(4):483-8. PubMed ID: 10747825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
    Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model.
    Nguyen HA; Grellet J; Paillard D; Dubois V; Quentin C; Saux MC
    J Antimicrob Chemother; 2006 May; 57(5):883-90. PubMed ID: 16533826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
    Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
    J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa.
    Ishida H; Ishida Y; Kurosaka Y; Otani T; Sato K; Kobayashi H
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1641-5. PubMed ID: 9660997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
    Van de Velde S; Nguyen HA; Van Bambeke F; Tulkens PM; Grellet J; Dubois V; Quentin C; Saux MC
    J Antimicrob Chemother; 2008 Sep; 62(3):518-21. PubMed ID: 18544595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?
    Bonfiglio G
    Chemotherapy; 2001; 47(4):239-42. PubMed ID: 11399859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonadifloxacin (WCK 771) exerts potent intracellular activity against
    Dubois J; Dubois M
    J Med Microbiol; 2019 Dec; 68(12):1716-1722. PubMed ID: 31689174
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
    Parte AC; Smith JT
    Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa.
    Segatore B; Setacci D; Perilli M; Franceschini N; Marchetti F; Amicosante G
    Int J Antimicrob Agents; 2000 Jan; 13(3):223-6. PubMed ID: 10724029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method.
    Tanaka M; Hoshino K; Hohmura M; Ishida H; Kitamura A; Sato K; Hayakawa I; Nishino T
    J Antimicrob Chemother; 1996 Jun; 37(6):1091-102. PubMed ID: 8836812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.
    Nguyen HA; Grellet J; Dubois V; Saux MC; Quentin C
    J Antimicrob Chemother; 2007 Apr; 59(4):755-8. PubMed ID: 17353222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells.
    García I; Pascual A; Ballesta S; Perea EJ
    Int J Antimicrob Agents; 2000 Aug; 15(3):201-5. PubMed ID: 10926442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
    Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates.
    Muller-Serieys C; Decré D; Benoit C; Bigot C; Maubert B; Carbon C
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():67-70. PubMed ID: 10404341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
    Houston AK; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):57-9. PubMed ID: 8026158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.